NeoDiagnostix Overview

  • Founded
  • 2005
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

NeoDiagnostix General Information

Description

Operator of a cancer diagnostics company. The company uses molecular DNA technologies with a substantial portfolio of proprietary biomarkers. The company provides clinicians with a patient's molecular profile that provides crucial insights into cancer leading to improved patient care.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Therapeutic Devices
Other Healthcare Technology Systems
Parent Company
Primary Office
  • 9700 Great Seneca Highway
  • Rockville, MD 20850
  • United States
+1 (240) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NeoDiagnostix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 01-Jan-2011 00.000 Completed Generating Revenue
5. Early Stage VC 27-Oct-2009 00.000 00.000 Completed Generating Revenue
4. Early Stage VC (Series A) 23-Oct-2008 00.000 00.000 Completed Startup
3. Early Stage VC 11-Jun-2007 00000 00.000 Completed Startup
2. Early Stage VC (Series A) 05-Mar-2007 $1.12M $1.17M 00.000 Completed Startup
1. Early Stage VC 30-Jun-2006 $50K $50K Completed Startup
To view NeoDiagnostix’s complete valuation and funding history, request access »

NeoDiagnostix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00 00 00 00.000
To view NeoDiagnostix’s complete cap table history, request access »

NeoDiagnostix Executive Team (4)

Name Title Board Seat Contact Info
Richard Pinnola Chief Executive Officer & President
Gregory Endress Chief Scientific Officer
Robert Gibbs Vice President Clinical Sales and Marketing
Mark Shear Vice President, Strategic Accounts
To view NeoDiagnostix’s complete executive team members history, request access »

NeoDiagnostix Board Members (2)

Name Representing Role Since
William Gust Self Board Member 000 0000
You’re viewing 1 of 2 board members. Get the full list »

NeoDiagnostix Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Maryland Department of Commerce Government Minority 000 0000 000000 0
Maryland Health Care Product Development Corporate Venture Capital Minority 000 0000 000000 0
To view NeoDiagnostix’s complete investors history, request access »